{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:56Z","timestamp":1772165696153,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Estimation of phosphate load in hemodialysis patients is always controversial in clinical practice. The aim of this study was to verify individual achievement rate of serum phosphate as the evaluation of phosphate load through investigating its impact on cardiovascular mortality in hemodialysis patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a single-center, retrospective cohort study. A total of 251 maintenance hemodialysis patients were enrolled. The individual achievement rate of serum phosphate was defined as the times of tests within the target range divided by total times of tests over a period of time. Cox regression model was used to examine the relationship between individual achievement rate of serum phosphate and cardiovascular mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of the study population was 61\u2009\u00b1\u200913\u2009years old. A total of 44 (17.5%) patients died from cardiovascular disease (CVD) during a median follow-up of 65\u2009months. Multivariable Cox analysis showed that one-year serum phosphate achievement rate of 0% (HR\u2009=\u20094.117,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.016) and 25% (HR\u2009=\u20093.343,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.023) increased the risk of cardiovascular mortality while the achievement rate of 50% (HR\u2009=\u20092.129,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.162) and 75% (HR\u2009=\u20091.080,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.902) did not, compared to the rate of 100%. Urea reduction ratio (URR) was positively, while serum intact parathyroid hormone (iPTH), alkaline phosphatase (ALP), normalized protein catabolic rate (nPCR), and total phosphate-binding capacity of drug were negatively associated with achievement in target of serum phosphate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Keeping one-year achievement rate of serum phosphate higher than 50% provides significant clinical benefits in reducing cardiovascular mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-021-02547-z","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T09:03:40Z","timestamp":1638349420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Higher one-year achievement rate of serum phosphate associated with lower cardiovascular mortality in hemodialysis patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Weichen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaori","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"3","key":"2547_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/ndt\/gfv370","volume":"31","author":"A Okparavero","year":"2016","unstructured":"Okparavero A, Foster MC, Tighiouart H, Gudnason V, Indridason O, Gudmundsdottir H, et al. Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland. Nephrol Dial Transplant. 2016;31(3):439\u201347.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2547_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1590\/2175-8239-jbn-3527","volume":"40","author":"RR Abrita","year":"2018","unstructured":"Abrita RR, Pereira BDS, Fernandes NDS, Abrita R, Huaira RMNH, Bastos MG, et al. Evaluation of prevalence, biochemical profile, and drugs associated with chronic kidney disease-mineral and bone disorder in 11 dialysis centers. Braz J Nephrol. 2018;40(1):26\u201334.","journal-title":"Braz J Nephrol"},{"issue":"5","key":"2547_CR3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","volume":"93","author":"MG Vervloet","year":"2018","unstructured":"Vervloet MG, van Ballegooijen AJ. Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int. 2018;93(5):1060\u201372.","journal-title":"Kidney Int"},{"issue":"12","key":"2547_CR4","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.2215\/CJN.03860411","volume":"6","author":"BU Agar","year":"2011","unstructured":"Agar BU, Akonur A, Lo Y, Cheung AK, Leypoldt JK. Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis. Clin J Am Soc Nephrol. 2011;6(12):2854\u201360.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2547_CR5","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.2215\/CJN.03280317","volume":"12","author":"HC Rayner","year":"2017","unstructured":"Rayner HC, Larkina M, Wang M, Graham-Brown M, van der Veer SN, Ecder T, et al. International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"2547_CR6","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1681\/ASN.2014050472","volume":"26","author":"MB Rivara","year":"2015","unstructured":"Rivara MB, Ravel V, Kalantar-Zadeh K, Streja E, Lau WL, Nissenson AR, et al. Uncorrected and albumin-corrected calcium, phosphorus, and mortality in patients undergoing maintenance dialysis. J Am Soc Nephrol. 2015;26(7):1671\u201381.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2547_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011;305(11):1119\u201327.","journal-title":"JAMA"},{"issue":"1","key":"2547_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1053\/j.jrn.2004.09.027","volume":"15","author":"Y Nishizawa","year":"2005","unstructured":"Nishizawa Y, Jono S, Ishimura E, Shioi A. Hyperphosphatemia and vascular calcification in end-stage renal disease. J Renal Nutr. 2005;15(1):178\u201382.","journal-title":"J Renal Nutr"},{"key":"2547_CR9","first-page":"S255","volume-title":"2006-01-01 2006","author":"SG Achinger","year":"2006","unstructured":"Achinger SG, Ayus JC. Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor? In:  2006-01-01 2006. Hagerstown: Lippincott Williams & Wilkins; 2006. p. S255\u201361."},{"issue":"3","key":"2547_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52(3):519\u201330.","journal-title":"Am J Kidney Dis"},{"key":"2547_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bone.2014.01.016","volume":"61","author":"E Streja","year":"2014","unstructured":"Streja E, Wang H, Lau WL, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K, et al. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone. 2014;61:201\u20137.","journal-title":"Bone"},{"issue":"2","key":"2547_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.ajkd.2015.01.009","volume":"66","author":"J Da","year":"2015","unstructured":"Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y, et al. Serum phosphorus and progression of CKD and mortality: a meta-analysis of cohort studies. Am J Kidney Dis. 2015;66(2):258\u201365.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2547_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.jrn.2013.01.018","volume":"23","author":"P Lertdumrongluk","year":"2013","unstructured":"Lertdumrongluk P, Rhee CM, Park J, Lau WL, Moradi H, Jing J, et al. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Renal Nutr. 2013;23(6):411\u201321.","journal-title":"J Renal Nutr"},{"issue":"6","key":"2547_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","volume":"70","author":"T Isakova","year":"2017","unstructured":"Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Guti\u00e9rrez OM, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737\u201351.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2547_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD\u2013mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2010;55(5):773\u201399.","journal-title":"Am J Kidney Dis"},{"key":"2547_CR16","unstructured":"K\/DOQI Work Group clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1\u2013S201."},{"issue":"14","key":"2547_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","volume":"329","author":"WJ Owen","year":"1993","unstructured":"Owen WJ, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329(14):1001\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"2547_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1681\/ASN.V451205","volume":"4","author":"JT Daugirdas","year":"1993","unstructured":"Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt\/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2547_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/01.ASN.0000117976.29592.93","volume":"15","author":"F Termorshuizen","year":"2004","unstructured":"Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15(4):1061\u201370.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2547_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/ajcn\/33.1.27","volume":"33","author":"PE Watson","year":"1980","unstructured":"Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33(1):27\u201339.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2547_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1525-139X.2011.00849.x","volume":"24","author":"JT Daugirdas","year":"2011","unstructured":"Daugirdas JT, Finn WF, Emmett M, Chertow GM. The phosphate binder equivalent dose. Semin Dialysis. 2011;24(1):41\u20139.","journal-title":"Semin Dialysis"},{"issue":"3","key":"2547_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1037\/1082-989X.12.3.317","volume":"12","author":"TJ Ozechowski","year":"2007","unstructured":"Ozechowski TJ, Turner CW, Hops H. Mixed-effects logistic regression for estimating transitional probabilities in sequentially coded observational data. Psychol Methods. 2007;12(3):317\u201335.","journal-title":"Psychol Methods"},{"issue":"3","key":"2547_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/TA.0000000000001796","volume":"84","author":"S Keihani","year":"2018","unstructured":"Keihani S, Xu Y, Presson AP, Hotaling JM, Nirula R, Piotrowski J, et al. Contemporary management of high-grade renal trauma. J Trauma Acute Care. 2018;84(3):418\u201325.","journal-title":"J Trauma Acute Care"},{"issue":"25","key":"2547_CR24","doi-asserted-by":"publisher","first-page":"e10937","DOI":"10.1097\/MD.0000000000010937","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, Yu J, Chen X, Quan X, Zhou L. Correlations between health-promoting lifestyle and health-related quality of life among elderly people with hypertension in Hengyang, Hunan, China. Medicine. 2018;97(25):e10937.","journal-title":"Medicine"},{"issue":"9","key":"2547_CR25","first-page":"1494","volume":"20","author":"MM Ward","year":"1993","unstructured":"Ward MM, Leigh JP. The relative importance of pain and functional disability to patients with rheumatoid arthritis. J Rheumatol. 1993;20(9):1494\u20139.","journal-title":"J Rheumatol"},{"issue":"6","key":"2547_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/sdi.12411","volume":"28","author":"AJ Felsenfeld","year":"2015","unstructured":"Felsenfeld AJ, Levine BS, Rodriguez M. Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease. Semin Dial. 2015;28(6):564\u201377.","journal-title":"Semin Dial"},{"issue":"3","key":"2547_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.kint.2017.02.014","volume":"92","author":"H Komaba","year":"2017","unstructured":"Komaba H, Kaludjerovic J, Hu DZ, Nagano K, Amano K, Ide N, et al. Klotho expression in osteocytes regulates bone metabolism and controls bone formation. Kidney Int. 2017;92(3):599\u2013611.","journal-title":"Kidney Int"},{"issue":"2","key":"2547_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2215\/CJN.04730510","volume":"6","author":"MG Vervloet","year":"2011","unstructured":"Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol. 2011;6(2):383\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2547_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/ndt\/gfs405","volume":"28","author":"M Sigrist","year":"2013","unstructured":"Sigrist M, Tang M, Beaulieu M, Espino-Hernandez G, Er L, Djurdjev O, et al. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant. 2013;28(1):161\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2547_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/ndt\/gfy093","volume":"34","author":"JL Fernandez-Martin","year":"2019","unstructured":"Fernandez-Martin JL, Dusso A, Martinez-Camblor P, Dionisi MP, Floege J, Ketteler M, et al. Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. Nephrol Dial Transplant. 2019;34(4):673\u201381.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2547_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5414\/CN109265","volume":"90","author":"M Zhu","year":"2018","unstructured":"Zhu M, Dou L, Zhu M, Liu S, Zhan Y, Lu J, et al. Variability of serum phosphorus and its association with mortality among hemodialysis patients. Clin Nephrol. 2018;90(2):79\u201386.","journal-title":"Clin Nephrol"},{"key":"2547_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bone.2015.11.005","volume":"83","author":"Z Dai","year":"2016","unstructured":"Dai Z, Wang R, Ang LW, Yuan JM, Koh WP. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population. Bone. 2016;83:171\u20137.","journal-title":"Bone"},{"issue":"5","key":"2547_CR33","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1681\/ASN.2017050584","volume":"29","author":"S Salam","year":"2018","unstructured":"Salam S, Gallagher O, Gossiel F, Paggiosi M, Khwaja A, Eastell R. Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy. J Am Soc Nephrol. 2018;29(5):1557\u201365.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2547_CR34","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s11255-019-02217-y","volume":"51","author":"Y Ge","year":"2019","unstructured":"Ge Y, Yang G, Wang N, Zha X, Yu X, Mao H, et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2019;51(8):1443\u20139.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"2547_CR35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","volume":"62","author":"S Sardiwal","year":"2013","unstructured":"Sardiwal S, Magnusson P, Goldsmith DJ, Lamb EJ. Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis. 2013;62(4):810\u201322.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2547_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12882-017-0692-5","volume":"18","author":"HS J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen HS, Winther S, B\u00f8ttcher M. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol. 2017;18(1):284.","journal-title":"BMC Nephrol"},{"issue":"5","key":"2547_CR37","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.kint.2018.12.015","volume":"95","author":"JM Diaz-Tocados","year":"2019","unstructured":"Diaz-Tocados JM, Rodriguez-Ortiz ME, Almaden Y, Pineda C, Martinez-Moreno JM, Herencia C, et al. Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration. Kidney Int. 2019;95(5):1064\u201378.","journal-title":"Kidney Int"},{"issue":"5","key":"2547_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/kisup.2013.96","volume":"3","author":"E Streja","year":"2013","unstructured":"Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, et al. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl. 2013;3(5):462\u20138.","journal-title":"Kidney Int Suppl"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02547-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02547-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02547-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T09:05:17Z","timestamp":1638349517000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02547-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2547"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02547-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-618500\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"12 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee on Human Research of Huashan Hospital, Fudan university (KY2021\u2013584). All the experiment protocol for involving human data was in accordance with the guidelines of Declaration of Helsinki. Written Informed consent was obtained from all patients enrolled in this study or their families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no relevant financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}